[Do advances in molecular biology change indications for adjuvant chemotherapy in colorectal cancer?].
Roque
I
I
Hôpital Charles-Nicolle, CHU, Rouen, France.
Michel
P
P
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy*; D006801:Humans; D018895:Microsatellite Repeats; D011379:Prognosis
D000970:Antineoplastic Agents